[talk about traditional Chinese medicine with Lao Bi] (1)

Talk about traditional Chinese medicine with Lao bi - from the number of traditional Chinese medicine, I was destined to enter the pharmaceutical industry at the time of establishment, reform and opening up China has changed from a single planned economic system to a socialist market economic system The traditional Chinese medicine industry has changed from decentralized management of production, supply and marketing to centralized and unified management, from separate management of industry and drug administration to centralized formation of drug supervision system, from the two-level management of the central and local approval number to the central level management after centralized collection However, the so-called focus of drug supervision has always been on one "Document number" (drug approval document number) and related drug review and approval system, including the "story" of the game between the manager and the managed "true and false" 30 years ago, according to the first drug administration law of China, which came into effect on July 1, 1985, the notice of [86] wyz No 84 document on comprehensively carrying out the rectification of varieties of Chinese patent medicine started the rectification of varieties of Chinese patent medicine for 10 years By the end of the rectification of local standards of Chinese patent medicine in 1996, the 1-20 volumes of Chinese patent medicine standard of the Ministry of health were collected and contained 4052 varieties There are 200 varieties in the first volume of Tibetan medicine, 87 varieties in the Uighur medicine, and 225 new traditional Chinese medicine drugs in the first to the 15th volume of the standard of new medicine rectification, with a total of 4564 varieties Due to the cancellation of local new drug approval authority in 1985, in the 10 years of 85-96, 225 new Chinese medicine drugs were approved in China, with an average of more than 20 in a year 15 years ago, the notice on strengthening the national standard management of Chinese patent medicine (gyjz [2001] No 83) was based on the revised Drug Management Law and GBH [2001] No 68 document, which was implemented on December 1, 2001 to rectify the landmark varieties In order to realize the regulation that the local standard varieties should not be circulated on the market from January 1, 2003 From December 1, 2001 to November 30, 2002, 13 volumes of the compilation of national standards for Chinese patent medicines (the part of local standards for Chinese patent medicines rising to national standards) were finally formed In less than two years, 1518 "new drugs" of traditional Chinese medicine have been rapidly increased in China, basically the "Resurrection" of landmark varieties that failed to pass the medical and pharmaceutical examination in the 10-year rectification of the Ministry of health So far, on January 1, 2003, the number of varieties of Chinese patent medicine issued by the state "quasi birth certificate" rose to 6082 What no one had expected was that Chinese medicine researchers, full of "wisdom", had a "great leap forward" in the generation of Chinese patent medicine number by virtue of the "loosening" of policy, almost doubling the number of 6000 varieties (to be continued, please pay attention to) [Note 1], [Note 3] zgjz [2001] No 83 notice on strengthening the national standard management of Chinese patent medicine [Note 2] zgjz [2001] No 522 notice on the implementation of relevant local drug standards [Note 4] index volume of national Chinese patent medicine standard collection